2 31/10/2023 30/10/2024 2024-10-30 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-10-31 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 07592952 2023-10-31 2024-10-30 07592952 2024-10-30 07592952 2023-10-30 07592952 2022-10-31 2023-10-30 07592952 2023-10-30 07592952 2022-10-30 07592952 bus:RegisteredOffice 2023-10-31 2024-10-30 07592952 bus:LeadAgentIfApplicable 2023-10-31 2024-10-30 07592952 bus:Director1 2023-10-31 2024-10-30 07592952 bus:Director2 2023-10-31 2024-10-30 07592952 bus:Director3 2023-10-31 2024-10-30 07592952 bus:Director4 2023-10-31 2024-10-30 07592952 bus:Director5 2023-10-31 2024-10-30 07592952 bus:Director6 2023-10-31 2024-10-30 07592952 core:PlantMachinery 2023-10-30 07592952 core:PlantMachinery 2024-10-30 07592952 core:WithinOneYear 2024-10-30 07592952 core:WithinOneYear 2023-10-30 07592952 core:ShareCapital 2024-10-30 07592952 core:ShareCapital 2023-10-30 07592952 core:RetainedEarningsAccumulatedLosses 2024-10-30 07592952 core:RetainedEarningsAccumulatedLosses 2023-10-30 07592952 core:PlantMachinery 2023-10-31 2024-10-30 07592952 core:CostValuation core:Non-currentFinancialInstruments 2024-10-30 07592952 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2023-10-30 07592952 core:ImpairmentLossProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2024-10-30 07592952 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2024-10-30 07592952 core:Non-currentFinancialInstruments 2024-10-30 07592952 core:Non-currentFinancialInstruments 2023-10-30 07592952 core:PlantMachinery 2023-10-30 07592952 bus:Director1 2023-10-30 07592952 bus:Director1 2024-10-30 07592952 bus:Director2 2023-10-30 07592952 bus:Director2 2024-10-30 07592952 bus:Director3 2023-10-30 07592952 bus:Director3 2024-10-30 07592952 bus:Director1 2022-10-30 07592952 bus:Director1 2023-10-30 07592952 bus:Director2 2022-10-30 07592952 bus:Director2 2023-10-30 07592952 bus:Director3 2022-10-30 07592952 bus:Director3 2023-10-30 07592952 bus:Director2 2022-10-31 2023-10-30 07592952 bus:SmallEntities 2023-10-31 2024-10-30 07592952 bus:AuditExemptWithAccountantsReport 2023-10-31 2024-10-30 07592952 bus:SmallCompaniesRegimeForAccounts 2023-10-31 2024-10-30 07592952 bus:PrivateLimitedCompanyLtd 2023-10-31 2024-10-30 07592952 bus:FullAccounts 2023-10-31 2024-10-30 07592952 core:ComputerEquipment 2023-10-30 07592952 core:ComputerEquipment 2023-10-31 2024-10-30 07592952 core:ComputerEquipment 2024-10-30
Company registration number: 07592952
Medical Skills Care Limited
Unaudited filleted financial statements
30 October 2024
Medical Skills Care Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Medical Skills Care Limited
Directors and other information
Directors Dr D J Marsh
Dr M D Smith
Mr T W Horton (Resigned 30 April 2025)
Dr S P Curtis
Dr P P Nichols
Ms F Smith (Appointed 30 April 2025)
Company number 07592952
Registered office 4th Floor 18 St. Cross Street
London
EC1N 8UN
Accountants Hicks and Company
Chartered Accountants
Vaughan Chambers
Vaughan Road
Harpenden
AL5 4EE
Medical Skills Care Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Medical Skills Care Limited
Year ended 30 October 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Medical Skills Care Limited for the year ended 30 October 2024 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Medical Skills Care Limited, as a body, in accordance with the terms of our engagement letter dated 6 August 2024. Our work has been undertaken solely to prepare for your approval the financial statements of Medical Skills Care Limited and state those matters that we have agreed to state to the board of directors of Medical Skills Care Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medical Skills Care Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Medical Skills Care Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Medical Skills Care Limited. You consider that Medical Skills Care Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Medical Skills Care Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Hicks and Company
Chartered Accountants
Vaughan Chambers
Vaughan Road
Harpenden
AL5 4EE
16 July 2025
Medical Skills Care Limited
Statement of financial position
30 October 2024
2024 2023
Note £ £ £ £
Fixed assets
Tangible assets 5 24,280 33,804
Investments 6 5,637 7,046
_______ _______
29,917 40,850
Current assets
Debtors 7 73,847 129,443
Cash at bank and in hand 288,890 244,502
_______ _______
362,737 373,945
Creditors: amounts falling due
within one year 8 ( 83,712) ( 103,183)
_______ _______
Net current assets 279,025 270,762
_______ _______
Total assets less current liabilities 308,942 311,612
Provisions for liabilities ( 6,070) ( 8,460)
_______ _______
Net assets 302,872 303,152
_______ _______
Capital and reserves
Called up share capital 250 250
Profit and loss account 302,622 302,902
_______ _______
Shareholders funds 302,872 303,152
_______ _______
For the year ending 30 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 16 July 2025 , and are signed on behalf of the board by:
Ms F Smith
Director
Company registration number: 07592952
Medical Skills Care Limited
Notes to the financial statements
Year ended 30 October 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4th Floor 18 St. Cross Street, London, EC1N 8UN.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Tangible assets
Tangible assets are initially recorded at cost, and is subsequently stated at cost less any accumulated depreciation and any accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery - Straight line over 3 years
Computer equipment - Straight line over 3 years
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 5 ).
5. Tangible assets
Plant and machinery Computer equipment Total
£ £ £
Cost
At 31 October 2023 51,542 22,281 73,823
Additions 5,498 7,753 13,251
_______ _______ _______
At 30 October 2024 57,040 30,034 87,074
_______ _______ _______
Depreciation
At 31 October 2023 27,133 12,886 40,019
Charge for the year 15,711 7,064 22,775
_______ _______ _______
At 30 October 2024 42,844 19,950 62,794
_______ _______ _______
Carrying amount
At 30 October 2024 14,196 10,084 24,280
_______ _______ _______
At 30 October 2023 24,409 9,395 33,804
_______ _______ _______
6. Investments
Other investments other than loans Total
£ £
Cost
At 31 October 2023 and 30 October 2024 15,500 15,500
_______ _______
Impairment
At 31 October 2023 8,454 8,454
Impairment loss 1,409 1,409
_______ _______
At 30 October 2024 9,863 9,863
_______ _______
Carrying amount
At 30 October 2024 5,637 5,637
_______ _______
At 30 October 2023 7,046 7,046
_______ _______
7. Debtors
2024 2023
£ £
Trade debtors 28,080 78,524
Other debtors 45,767 50,919
_______ _______
73,847 129,443
_______ _______
8. Creditors: amounts falling due within one year
2024 2023
£ £
Trade creditors 13,186 6,216
Corporation tax 31,901 38,637
Social security and other taxes 13,498 22,485
Other creditors 25,127 35,845
_______ _______
83,712 103,183
_______ _______
9. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Dr D J Marsh ( 6,916) - ( 6,916)
Dr M D Smith 19,095 430 19,525
Mr T W Horton ( 623) 70 ( 553)
_______ _______ _______
11,556 500 12,056
_______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Balance o/standing
£ £ £
Dr D J Marsh ( 6,916) - ( 6,916)
Dr M D Smith 6,980 12,115 19,095
Mr T W Horton ( 623) - ( 623)
_______ _______ _______
( 559) 12,115 11,556
_______ _______ _______